Physician profile
Marcia E Little
NPI 1376509422
$876.62
in general payments reported to CMS, 2019-2025
13 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2021: $27.17 · 2022: $214 · 2023: $257 · 2024: $104 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $257.17 | 2023 | Arista Ah Flexitip |
| Sanofi Pasteur INC. | $126.69 | 2025 | |
| Medical Device Business Services, INC. | $125.00 | 2022 | |
| Astellas Pharma Global Development | $83.81 | 2024 | Veozah |
| Coopersurgical, INC. | $72.25 | 2019 | |
| Astellas Pharma US INC | $61.95 | 2022 | |
| Organon LLC | $29.54 | 2025 | Jada System |
| Alydia Health | $27.17 | 2021 | |
| Meditrina | $27.03 | 2022 | |
| Solventum Corporation | $19.75 | 2024 | Prevena |
| Smith+Nephew, INC. | $17.92 | 2019 | |
| Allergan, INC. | $16.13 | 2019 | |
| Abbvie INC. | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcia Little listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.